KLOW is a co-lyophilized four-component peptide research blend combining GHK-Cu, BPC-157, TB-500, and KPV in a fixed ratio, commonly referenced in laboratory research for simultaneous investigation of ECM remodeling, angiogenic signaling, cytoskeletal dynamics, and NF-B inflammatory pathway modulation
It's a clinically supervised program that starts with comprehensive baseline labs, pairs you with a physician who understands longevity medicine, and builds a personalized protocol that may include peptide therapy alongside other interventions, such as GLP-1 support through GLP-1 Longevity Care for those with appropriate metabolic indications, or foundational longevity support through Foundayo Pill with Ongoing Care
DMPS : SODIUM 2.3 DIMERCAPTOPROPANE-L-SULPHONATE is used as a treatment for exposure to heavy metals including mercury, arsenic, and lead
Steve walks you through it all